HansBiomed Corporation (KOSDAQ:042520)

Revenue by Segment

Financials in millions KRW. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Other Section	7.76B	6.26B	5.21B	4.32B	4.23B
Other Section Growth	23.86%	20.27%	20.44%	2.20%	-89.06%
Medical Device Division	46.92B	55.50B	54.83B	54.59B	43.79B
Medical Device Division Growth	-15.45%	1.21%	0.45%	24.65%	7.08%
Human Tissue Section	73.78B	51.98B	48.98B	43.37B	34.03B
Human Tissue Section Growth	41.93%	6.13%	12.93%	27.46%	5.19%
Unallocated Adjustment	-38.68B	-32.61B	-30.99B	-27.82B	-22.95B
Total	89.78B	81.14B	78.03B	74.46B	59.10B
Total Growth	10.65%	3.98%	4.80%	25.99%	-26.22%

Revenue by Geography

Financials in millions KRW. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
South Korea	57.85B	43.47B	41.05B	34.72B	24.68B
South Korea Growth	33.08%	5.89%	18.24%	40.70%	-43.89%
North America	14.56B	19.72B	19.86B	22.77B	16.63B
North America Growth	-26.20%	-0.67%	-12.79%	36.90%	-
Asia	12.05B	10.53B	8.73B	9.14B	11.25B
Asia Growth	14.41%	20.57%	-4.46%	-18.79%	-
South America	1.87B	4.91B	5.41B	4.19B	2.08B
South America Growth	-61.96%	-9.33%	29.28%	100.80%	-78.93%
Europe	1.28B	1.72B	2.26B	2.90B	2.75B
Europe Growth	-25.44%	-23.79%	-22.03%	5.39%	27.09%
Other	2.18B	787.07M	721.64M	747.36M	1.70B
Other Growth	176.53%	9.07%	-3.44%	-56.05%	-8.10%
Total	89.78B	81.14B	78.03B	74.46B	59.10B
Total Growth	10.65%	3.98%	4.80%	25.99%	-26.22%

Source: S&P Global Market Intelligence.